Citadel Advisors LLC
- SEC CIK
- 0001423053
- Latest filing
- Sep 1, 2026
ATXI holding history
Avenue Therapeutics, Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ATXI overviewAll 13F holders of ATXIFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −88,645−100.0% | Sold out | Holders |
| Q4 2023 | 88,645 | $14.4K | <0.1% | +88,645 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −35,865−100.0% | Sold out | Holders |
| Q3 2022 | 35,865 | $362.0K | <0.1% | +35,865 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −117,674−100.0% | Sold out | Holders |
| Q1 2022 | 117,674 | $57.0K | <0.1% | +93,447+385.7% | Added | Holders |
| Q4 2021 | 24,227 | $22.0K | <0.1% | −3,328−12.1% | Reduced | Holders |
| Q3 2021 | 27,555 | $41.0K | <0.1% | +27,555 | New | Holders |